France records two new deaths associated with the AstraZeneca coronavirus vaccine

The health authorities of France indicated this Friday that there have been three new cases of atypical thrombosis associated with the AstraZeneca against him coronavirus, including two deaths, bringing the total number of deaths linked to this product to four.

The balance presented by the French National Medicines Agency (ANSM) covers the period between the past 19 and 25 March and with them the number of cases of thrombosis reaches 12 and the number of deaths to four.

The agency indicated that they occurred on average about nine days after receiving the vaccination. Those affected were mainly women, nine of them under the age of 55 and another three older, and with no particular common history.

The ANSM specified that this is something very unusual and recalled that the European Medicines Agency (EMA) has stressed that the balance between the benefits and risks of vaccination with AstraZeneca to combat the covid-19 leans to the positive side.

The agency advised vaccinated individuals to consult their doctor immediately in case they have persistent symptoms after vaccination, such as leg swelling, abdominal or chest pain, or severe headaches.